Trial Profile

Prasugrel Versus High Dose Clopidogrel in Patients With Stable Coronary Artery Disease and High Platelet Reactivity While on Chronic Clopidogrel Treatment.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 08 Sep 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Prasugrel (Primary) ; Clopidogrel
Indications Coronary artery disease; Embolism and thrombosis
Focus Pharmacodynamics

Most Recent Events

31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
31 Aug 2011 Primary endpoint 'Platelet-aggregation' has been met.
21 Apr 2011 Actual end date (April 2011) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com